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Building, University Walk, Bristol University, Bristol BS8 1TD, UKAbstract—Experiences with a high degree of emotional
salience are better remembered than events that have little
emotional context and the amygdala is thought to play an
important role in this enhancement of memory. Visual
recognition memory relies on synaptic plasticity in the per-
irhinal cortex but little is known about the mechanisms that
may underlie emotional enhancement of this form of mem-
ory. There is good evidence that noradrenaline acting via
b-adrenoceptors (b-ADRs) can enhance memory consolida-
tion. In the present study we examine the role of b-ADRs in
synaptic plasticity at the amygdala–perirhinal pathway
(LA–PRh) and compare this to mechanisms of intra-perirhinal
(PRh–PRh) synaptic plasticity. We demonstrate that activity-
dependent PRh–PRh long-term potentiation (LTP) does not
rely on b1- or b2-ADRs and that LA–PRh LTP relies on
b1-ADRs but not b2-ADRs. We further demonstrate that
application of the b-ADR agonist isoprenaline produces last-
ing PRh–PRh potentiation but only transient potentiation at
the LA–PRh input. However, at the LA–PRh input, combin-
ing stimulation that is subthreshold for LTP induction with
isoprenaline results in long-lasting potentiation. Isoprenaline-
induced and isoprenaline plus subthreshold stimulation-
induced potentiation in the PRh–PRh and LA–PRh inputs,
respectively were both dependent on activation of NMDARs
(N-methyl-D-aspartate receptors), voltage-gated calcium
channels and PKA (protein kinase A). Understanding the
mechanisms of amygdala–perirhinal cortex plasticity will
allow a greater understanding of how emotionally-charged
events are remembered.  2014 The Authors. Published by
Elsevier Ltd. on behalf of IBRO. This is anopenaccess article
under the CC BY license (http://creativecommons.org/
licenses/by/3.0/).
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INTRODUCTION
The familiarity discrimination component of visual
recognition memory requires the perirhinal cortex
(Gaﬀan and Murray, 1992; Fahy et al., 1993; Suzukihttp://dx.doi.org/10.1016/j.neuroscience.2014.04.070
0306-4522/ 2014 The Authors. Published by Elsevier Ltd. on behalf of IBRO.
This is an open access article under the CC BY license (http://creativecommons.org
*Corresponding author. Tel: +44-117-3311957.
E-mail address: z.i.bashir@bristol.ac.uk (Z. I. Bashir).
Abbreviations: DMSO, dimethyl sulfoxide; fEPSP, ﬁeld excitatory
postsynaptic potential; LA, lateral amygdala; LTP, long-term
potentiation; PRh, perirhinal; b-ADR, b-adrenoceptors.
163et al., 1993; Suzuki, 1996; Ennaceur and Aggleton,
1997; Murray and Bussey, 1999) and synaptic plasticity
in the perirhinal cortex may provide the cellular mecha-
nisms underlying recognition memory (Warburton et al.,
2003; Griﬃths et al., 2008; Massey et al., 2008).
The amygdala has an established role in fear-
conditioning paradigms (Blair et al., 2001; Schafe et al.,
2001; Maren and Quirk, 2004; Johansen et al., 2010)
and is a likely site for the storage of these types of mem-
ory (Rogan et al., 1997; Fanselow and LeDoux, 1999;
Blair et al., 2001). However, a less well deﬁned yet highly
important role of the amygdala is its ability to inﬂuence
other forms of memory, particularly when the learning epi-
sode has a degree of emotional context (Paz et al., 2006).
Experiences with a high degree of emotional context
are better remembered than events with less emotional
context (McGaugh et al., 2002; Roozendaal et al., 2006,
2009). Application of hormones related to stress and
emotions, such as adrenaline or corticosterone, can
increase memory consolidation (Roozendaal et al.,
2006, 2008, 2009; Barsegyan et al., 2010). The mecha-
nisms by which stress hormones bring about memory
consolidation are not well understood but activation of
b-adrenoceptors (b-ADR) in the amygdala can enhance
object recognition memory (Roozendaal et al., 2008). This
suggests a potentially important role of the amygdala in
memory consolidation. Activity of the amygdala can regu-
late cortical activity (Pelletier et al., 2005; Bauer et al.,
2007) and can directly inﬂuence the spread of neuronal
activity from the perirhinal cortex to the entorhinal cortex
(Pitka¨nen et al., 2000; Kajiwara et al., 2003; Paz et al.,
2006; Furtak et al., 2007a). These studies suggest that
the amygdala is functionally connected with the perirhinal
cortex and indeed the amygdala has strong reciprocal
connections with the perirhinal cortex (Pitka¨nen et al.,
2000). Taken together, these studies suggest that the
amygdala may profoundly inﬂuence the mechanisms of
recognition memory by direct actions on the perirhinal
cortex.
Given that visual recognition memory relies on
synaptic plasticity within the perirhinal cortex (Warburton
et al., 2003; Griﬃths et al., 2008; Massey et al., 2008) it
is possible that synaptic transmission or plasticity at the
amygdala–perirhinal synapses may be involved in the
adrenergic and emotional enhancement of recognition
memory. We recently described mechanisms of synaptic
plasticity at amygdala–perirhinal synapses and how this
input can inﬂuence intracortical perirhinal long-term
potentiation (LTP) (Perugini et al., 2012). However, little/licenses/by/3.0/).
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synaptic plasticity in the perirhinal cortex or in the regula-
tion of amygdala to perirhinal cortex synapses. Therefore,
the aim of this study was to further examine in an in vitro
rat brain slice preparation how synaptic communication
at the amygdala–perirhinal cortex synapses and at
intracortical perirhinal synapses is inﬂuenced by b-ADR
activation.
The perirhinal cortex itself is required for visual object
recognition (Gaﬀan and Murray, 1992; Fahy et al., 1993;
Suzuki et al., 1993; Suzuki, 1996; Ennaceur and
Aggleton, 1997; Murray and Bussey, 1999) and it is
known that activation of the noradrenergic system within
the amygdala can enhance object recognition memory
(Roozendaal et al., 2008).EXPERIMENTAL PROCEDURES
Juvenile male Lister Hooded rats of 30–35 days of age
(70–100 g; Harlan Laboratories, Hillcrest, UK) were
maintained on a 12-h light/dark cycle (dark phase during
normal daylight). All eﬀorts were made to minimize
animal suﬀering, and experiments were performed in
accordance with the UK Animals (Scientiﬁc Procedures)
Act (1986) and had received ethical approval.Slice preparation and electrophysiology
Animals were anesthetized with an isoﬂurane/oxygen
mixture and decapitated, and the brain rapidly removed.
Standard procedures were used for brain slice
preparation and in vitro extracellular recording. These
procedures are detailed fully in Perugini et al. (2012).
Brieﬂy, 400-lm thick slices containing perirhinal cortex
and lateral nucleus of the amygdala were prepared and
stored in standard aCSF (artiﬁcial cerebrospinal ﬂuid) at
room temperature before use. Single slices were then
used for recording at 30–32 C. Evoked ﬁeld excitatory
postsynaptic potentials (fEPSPs) were recorded with a
microelectrode (borosilicate glass micropipette ﬁlled with
aCSF, 2–5 MX) placed in layers II/III of the perirhinal
cortex (Massey et al. 2004; Ziakopoulos et al. 1999).
Two bipolar stimulation electrodes were placed on the
slice: one electrode in layers II/III of the perirhinal cortex,
and designated the intracortical input (PRh–PRh). The
second stimulating electrode was placed in the lateral
amygdala and designated the amygdala input (LA–PRh)
(see Fig. 1A). Each input was stimulated at a frequency
of 0.033 Hz. In a subset of experiments (Fig. 3D), two
stimulating electrodes were placed 1.5 mm apart in the
lateral amygdala to stimulate amygdala–perirhinal inputs,
that were independent of each other. The peak amplitude
of fEPSPs was measured and expressed relative to
the preconditioning baseline using the LTP program
(Anderson & Collingridge, 2001). In all experiments
input/output curves were produced by stimulating initially
at ‘‘minimal’’ intensity and increased intensities in 3-V
steps until the maximal fEPSP was achieved. As can be
seen in Fig. 1 the LA–PRh stimulation produces fEPSPs
that are very much smaller than with PRh–PRh stimula-
tion and this diﬀerence most likely reﬂects the relatively
fewer ﬁbers that reach the PRh cortex from amygdalawithin the slice preparation. fEPSPs were reduced to
40–50% of the maximum amplitude to achieve a baseline
of synaptic transmission. For induction of LTP the follow-
ing protocols were used: (1) HFS (high frequency stimula-
tion) – four trains of 100 pulses at 100-Hz, 30-s inter-train
intervals to either the PRh–PRh or the LA–PRh. (2) for a
subset of experiments (Fig. 3) a subthreshold-LTP
protocol was applied to the LA–PRh pathway: one train
of ﬁve pulses at 100-Hz. For all experiments the ﬁeld
potentials were ﬁltered at 5 kHz and digitized at 20 kHz.
LTP was measured at 60 min after induction. Changes
in response properties were assessed with SigmaPlot
12.0 or GraphPad Prism 6 (where appropriate) using
paired or unpaired samples t tests or one-way analysis
of variances (ANOVAs).Pharmacological agents
Compounds were obtained from Tocris Bioscience
(Bristol, UK) and prepared as stock solutions (1–10 mM)
by dilution in either dimethyl sulfoxide (DMSO) or
double-distilled water (ddH2O) and stored at 20 C.
Compounds were diluted in aCSF and bath applied at
the following concentrations: 20 lM verapamil
hydrochloride (ddH2O), 15 lM H89 dihydrochloride
(ddH2O), 200 nM KT 5720 (DMSO), 10 lM nifedipine
(DMSO), 10 lM isoprenaline hydrochloride (ddH2O),
5 lM L-689,560 (DMSO), 1 lM metoprolol tartrate
(ddH2O), 100 nM ICI 118,551 hydrochloride (DMSO) and
100 nM formoterol hemifumarate (ddH2O).RESULTS
LTP at amygdala to perirhinal synapses requires b1
but not b2-ADRs
We have previously reported that activity-dependent LTP
at amygdala–perirhinal (LA–PRh) synapses was
prevented by the broad-spectrum b-ADR antagonist
propranolol but, in contrast, LTP at perirhinal–perirhinal
(PRh–PRh) synapses was not sensitive to propranolol
treatment (Perugini et al., 2012). In this study we ﬁrst
sought to examine the subtypes of b-ADRs involved in
LTP.
The placement of recording and stimulating
electrodes is illustrated in Fig. 1A. Using this placement
we ﬁrstly conﬁrmed (Perugini et al., 2012) that LTP was
induced in both the LA–PRh pathway (148%± 4%,
t= 4.5, P= 0.004, N= 11, data not shown) and in the
PRh–PRh pathway (138 ± 6%, t= 5.4, P= 0.0005,
N= 11, data not shown). Bath application of the selective
b1-ADR antagonist, metoprolol (1 lM) prevented the
induction of LA–PRh LTP (103 ± 6%, t= 0.44,
P= 0.34; N= 6, Fig. 1B). In contrast, bath application
of the selective b2-ADR antagonist ICI 118,551
(100 nM) did not block LA–PRh LTP (166 ± 12%,
t= 8.7, P= 0.0001, N= 10, Fig. 1C). LTP was induced
at the PRh–PRh input in presence of either the b1-ADR
speciﬁc antagonist metoprolol (129%± 7%, t= 2.76,
P= 0.025, N= 6, Fig. 1B) or the b2-ADR antagonist
ICI 118,551 (129 ± 5%, t= 5.2, P= 0.00062, N= 9,
Fig. 1C). The lack of eﬀect of the b1- or b2-ADR
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Fig. 1. LA–PRh but not PRh–PRh LTP is dependent on b-ADRs. (A) Schematic diagram illustrating the electrode placement in horizontal slices,
containing the lateral amygdala and the perirhinal cortex. (B) Metoprolol blocked LA–PRh LTP. (B1) Pooled data (N= 6) demonstrating that bath
application of the b1-speciﬁc ADR antagonist metoprolol (1 lM) prevented the induction of LTP in the LA–PRh input (s, P= 0.34) but not at the
PRh–PRh input (d, P= 0.025). (B2) Example PRh–PRh traces highlighting the baseline (black) and 1 h after the delivery of HFS (red). (B3)
Example of LA–PRh traces highlighting the baseline (black) and 1 h after the delivery of HFS (red). (C) ICI 118,551 did not block LTP. (C1) Pooled
data (PRh–PRh: N= 9, LA–PRh: N= 10) demonstrating that application of the b2-speciﬁc ADR antagonist ICI 118,551 (100 nM) did not block LTP
in the LA–PRh (s, P 6 0.0001) or in the PRh–PRh (d, P= 0.00062) inputs. (C2) Example of PRh–PRh traces highlighting the baseline (black) and
1 h after the delivery of HFS (red). (C3) Example of traces for the LA–PRh pathway before (black) and after the delivery of the HFS (red). (D) b-ADR
agonism did not alter LTP. (D1) Pooled data (N= 5) demonstrating that bath application of the b2-speciﬁc b-ADR agonist formoterol (100 nM) did
not alter LTP compared to controls (PRh–PRh P= 0.47, LA–PRh P= 0.26). (D2) Example of PRh–PRh traces highlighting the baseline (black) and
1 h after the delivery of HFS (red). (D3) Example of LA–PRh traces highlighting the baseline (black) and 1 h after the delivery of HFS (red). In this
and all subsequent ﬁgures the values for the x and y axes of scale bars is as in panel (B2) and (B3). (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article.)
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ing, given we have previously demonstrated that the
broad-spectrum b-ADR antagonist propranolol did not
aﬀect LTP at the PRh–PRh input (Perugini et al., 2012).
While the level of LA–PRh LTP in the presence of the
b2-ADR antagonist IC1 118,551 (166 ± 12%) was not
signiﬁcantly greater (P=0.22) than control LTP
(148%± 4%), there was nevertheless a trend toward
larger LTP under these conditions (see Fig. 1C). This
raises the possibility that under normal conditions there
may be some degree of suppression of LTP by
endogenous activation of b2-ADRs. Therefore, to
examine if this was the case we performed experiments
in the presence of the b2-ADR agonist formoterol
(100 nM). However, in the presence of formoterol the
magnitude of LTP was no diﬀerent to control LTP in
either the PRh–PRh pathway (134± 4%, t=3.5,
P=0.47, N=5, Fig. 1D) or the LA–PRh pathway
(150± 4%, t=3.0, P=0.26, N=5, Fig. 1D); this
suggests it is unlikely that b2-ADR activation suppresses
LTP under the conditions of these experiments.
Pharmacological activation of b-ADRs at PRh–PRh
and LA–PRh synapses
In line with our previous ﬁndings (Perugini et al., 2012),
the above results demonstrate that LTP induced by HFS
at PRh–PRh synapses did not rely on b-ADRs but LTP
at LA–PRh synapses did rely on b-ADRs. However, we
have previously demonstrated at the PRh–PRh pathway
that application of the b-ADR agonist isoprenaline, at a
concentration (1 lM) that had no overt eﬀects on synaptic
transmission, could promote the induction of LTP by a
stimulus protocol that is normally the subthreshold for
LTP induction (Perugini et al., 2012).
Therefore to more fully examine the role of b-ADRs in
LTP we now performed experiments with bath application
of 10 lM isoprenaline. Under these conditions, the
application of isoprenaline alone resulted in a
potentiation within the PRh–PRh pathway that persisted
for at least 1 h after washout (126 ± 6%, t= 3.05,
P= 0.029, N= 6, Fig. 2A). Surprisingly however, in the
LA–PRh pathway only a transient potentiation was
observed (measured 10 min into drug application,
116 ± 3%, t= 3.7, P= 0.028, N= 6, Fig. 2A) and this
readily returned to the baseline upon washout of
isoprenaline (measured 1 h after washout, 94%± 4%,
t= 2.16, P= 0.16, N= 6, Fig. 2A).
These data, showing that application of isoprenaline
resulted in LTP at the PRh–PRh input but not at the LA–
PRh input, were surprising given our previous results
(Perugini et al., 2012) and the current data demonstrating
that b-ADR antagonists block activity-dependent LTP at
the LA–PRh pathway but not at PRh–PRh synapses. The
isoprenaline result suggests that appropriate activation of
b-ADRshas thepotential to enhancesynaptic transmission
in both PRh–PRh and LA–PRh pathways but that very
diﬀerent conditions may be required in the two pathways.
We next examined whether the potentiation induced
by bath application of isoprenaline was mediated by b1-
or b2-ADRs. Under the conditions of the present
experiments we found that the b1-ADR antagonistmetoprolol prevented the lasting potentiation induced by
isoprenaline in the PRh–PRh input and the transient
potentiation in the LA–PRh inputs (PRh–PRh: 99 ± 7%,
P= 0.56, N= 6, Fig. 2D; LA–PRh: 93 ± 9%,
P= 0.45, N= 6, Fig. 2E). In addition, the b2-ADR
antagonist ICI 118,551 also prevented potentiation by
isoprenaline in both inputs (PRh–PRh: 94 ± 5%,
P= 0.32, N= 4, Fig. 2D; LA–PRh: 88 ± 8%,
P= 0.34, N= 4, Fig. 2E).Mechanisms of isoprenaline-induced potentiation
We next tested whether the potentiation by isoprenaline
relies upon synaptic stimulation. To achieve this,
stimulation was turned oﬀ during isoprenaline application
and was not resumed until 20 min after isoprenaline had
been washed out. Under these conditions no potentiation
was observed in either pathway (PRh–PRh; 100%± 5%,
t= 0.75, P= 0.12, N= 3, Fig. 2B; LA–PRh; 96%±
6%, t= 0.88, P= 0.22, N= 3, Fig. 2B).
That isoprenaline produced potentiation in a stimulus-
dependent manner at the PRh–PRh synapses suggested
that activation of some other receptor systems are also
required for the induction of lasting potentiation. To
examine this possibility isoprenaline was applied in the
presence of the NMDAR (N-methyl-D-aspartate
receptor) antagonist L-689,560 (5 lM); under these
conditions application of isoprenaline did not result in
LTP in the PRh–PRh pathway (PRh–PRh; 105%± 3%,
t= 0.91, P= 0.45, N= 6, Fig. 2C) and did not produce
a transient potentiation in the LA–PRh pathway (LA–
PRh; 111 ± 6%, t= 0.96, P= 0.24, N= 6, Fig. 2C).
Similarly, isoprenaline-induced lasting potentiation in the
PRh–PRh pathway and transient potentiation in the LA–
PRh pathway was prevented by either of the voltage-
gated calcium channel inhibitors verapamil (PRh–PRh;
88.0%± 6%, t= 0.13, P= 0.91, N= 5, Fig. 2D; LA–
PRh; 97%± 10%, t= 2.20, P= 0.160, N= 5,
Fig. 2E) or nifedipine (PRh–PRh; 100 ± 6%, t= 0.46,
P= 0.68, N= 5, Fig. 2D; LA–PRh; 91%± 4%,
t= 2.5, P= 0.088, N= 5, Fig. 2E).
We have previously shown that b-ADR-dependent
LTP in the LA–PRh input relied on activation of PKA
(protein kinase A) signaling (Perugini et al., 2012). In
the current experiments we examined whether the iso-
prenaline-induced potentiation was also dependent on
activation of PKA. We found that the PKA inhibitors KT
5720 (200 nM) or H89 (15 lM) prevented isoprenaline-
induced lasting potentiation at PRh–PRh synapses (KT
5720: 99%± 4%, t= 1.7, P= 0.15, N= 4, Fig. 2D;
H89: 108 ± 11%, t= 0.095, P= 0.93, N= 5,
Fig. 2D) and prevented the transient potentiation at LA–
PRh synapses (KT 5720: 99%± 8%; t= 1.1,
P= 0.32, N= 4, Fig. 2E; H89: 105%± 5%, t= 1.9,
P= 0.20, N= 6, Fig. 2E).Lack of occlusion between isoprenaline potentiation
and LTP at the PRh–PRh synapses
Two stimulating electrodes were placed intracortically to
stimulate separate PRh–PRh inputs. HFS was delivered
to input one (F(1,3) = 15, P= 0.003) to induce LTP
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Fig. 2. b-ADR activation by isoprenaline induced LTP in the PRh–PRh pathway, that was dependent on NMDA receptors, VGCCs and PKA
signaling. (A) Isoprenaline (10 lM) induced LTP in the PRh–PRh pathway but only a transient potentiation in the LA–PRh pathway. (A1) Pooled data
(N= 6) demonstrating the isoprenaline-induced potentiation in the PRh–PRh pathway (d) and the LA–PRh pathway (s). (A2) Example of traces for
the PRh–PRh pathway, during baseline (black) and 1 h after (red) bath application of isoprenaline. (A3) Example of traces for the LA–PRh pathway
during baseline (black) and 10–20 min into (red) bath application of isoprenaline. (B) Isoprenaline-induced potentiation of the PRh–PRh input did not
occur if stimulation to the slice was ceased during isoprenaline application, and 20 min following washout. (B1) Pooled data (N= 3) demonstrating
that isoprenaline-induced potentiation of the PRh–PRh pathway (d) was prevented (PRh–PRh: P= 0.12). (B2) Example of traces of the PRh–PRh
pathway, during baseline (black) and at the end of the experiment (red). (B3) Example of traces for the LA–PRh pathway during baseline (black) and
at the end of the experiment (red). (C) Pre-application of the NMDAR antagonist L-689,560 (5 lM) blocked isoprenaline-induced potentiation. (C1)
Pooled data (N= 6) demonstrating that isoprenaline-induced potentiation was blocked in both the PRh–PRh (d, P= 0.45) and the LA–PRh inputs
(s, P= 0.24) when isoprenaline was co-applied with L-689,560. (C2) Example of traces of the PRh–PRh pathway, during baseline (black) and at
(red) the end of the experiment. (C3) Example of traces of the LA–PRh pathway, during baseline (black) and during (red) the co-application of
isoprenaline and L-689,560 (10–20 min into co-application). (D) PRh–PRh histogram highlighting that the potentiation observed with the bath
application of isoprenaline was blocked by antagonism of b1- or b2-ADRs, VGCCs (verapamil 20 lM or nifedipine 10 lM) or PKA (KT 5720 200 nM
or H89 15 lM) or. (E) LA–PRh histogram highlighting that the potentiation observed with the bath application of isoprenaline was blocked by
antagonism of b1- or b2-ADRs, VGCCs (verapamil 20 lM or nifedipine 10 lM) or PKA (KT 5720 200 nM or H89 15 lM) Antagonism of either the
b1-ADRs (metoprolol) or the b2-ADRs (ICI 118,551) was suﬃcient to prevent isoprenaline-induced potentiation (measurements taken 10–20 min
into co-application). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 3. Isoprenaline application did not occlude further potentiation
by HFS and vice versa. Example of traces for input 1 (d) of the PRh–
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168 M. Laing, Z. I. Bashir / Neuroscience 273 (2014) 163–173(126 ± 6%, P= 0.032, N= 4, Fig. 3). Isoprenaline was
subsequently applied and this resulted in further
potentiation in the input in which LTP had already been
induced (159 ± 8%, P= 0.023, N= 4, Fig. 3) and in
the input (F(1,2) = 17, P= 0.004) which had not
received HFS (input two, 124 ± 4%, P= 0.01, N= 4,
Fig. 3). After 40 min of isoprenaline application HFS was
delivered to the input that had not previously received
HFS. This resulted in further sustained potentiation
(160 ± 8%, P= 0.01, N= 4, Fig. 3). Therefore these
two forms of potentiation do not occlude one another
suggesting that diﬀerent mechanisms may be
responsible for their expression.Activation of b-ADRs by isoprenaline lowers the
threshold for LTP at the LA–PRh pathway
The results so far suggest that activation of b-ADRs may
be necessary but not suﬃcient for LA–PRh LTP.
Therefore it is possible that activation of other receptors
was also necessary for activity-dependent LA–PRh LTP.
To begin to examine this possibility we ﬁrst identiﬁed a
protocol which, on its own, was not capable of
producing LTP in the LA–PRh pathway (ﬁve pulses at
100-Hz; 98 ± 3%, t= 0.75, P= 0.25, N= 6, Fig. 4A).
We then coupled this protocol with bath application of
isoprenaline (10 lM). Under these conditions, long-
lasting potentiation was observed (LA–PRh;
134%± 6%; t= 3.1, P= 0.026, N= 6, Fig. 4B). We
therefore conclude that LA–PRh LTP can be induced by
pharmacological activation of b-ADRs in conjunction
with activation of some other mechanisms. Therefore,
we repeated the above experiment and found that LTPwas prevented by the NMDAR antagonist L-689,560
(LA–PRh; 104%± 11%; t= 1.7, P= 0.095, N= 6,
Fig. 4C), the voltage-gated calcium channel inhibitor
verapamil (LA–PRh; 96%± 3%, t= 0.81, P= 0.24,
N= 4, Fig. 4C) or the PKA inhibitor H89 (LA–PRh;
96%± 4%, t= 2.4, P= 0.067, N= 3, Fig. 4C).
Therefore LTP in the LA–PRh pathway requires the
activation of b-ADRs, NMDARs, voltage-gated calcium
channels and PKA signaling, when induced by
isoprenaline combined with subthreshold synaptic
stimulation.
Occlusion between isoprenaline potentiation and
LTP at the PRh-LA synapses
Two stimulation electrodes were placed in the lateral
amygdala to stimulate independent LA–PRh inputs. HFS
was delivered to input one (F(2,9) = 5, P= 0.031) and
this resulted in LTP (164 ± 8%, P= 0.033, N= 4,
Fig. 5). Isoprenaline was then bath applied 30 min after
LTP induction. Further potentiation was not induced in
this input by the subthreshold induction protocol in the
presence of isoprenaline (162 ± 11%, P= 0.77, N= 4,
Fig. 5). In the second input (F(2,9) = 9, P= 0.007)
isoprenaline produced potentiation that was sustained
when coupled with subthreshold stimulation (138 ± 8%,
P= 0.014, N= 4, Fig. 5). HFS delivered 30 min later
did not produce any further potentiation at this input
(147 ± 11%, P= 0.082, N= 4, Fig. 5). This shows that
isoprenaline-facilitated LTP occludes HFS-induced LTP
at the LA–PRh input, suggesting similar mechanisms
likely underlie both forms of LTP.
In the ﬁnal set of experiments we investigated whether,
to induce LTP, subthreshold HFS needs to be delivered
during the transient enhancement of transmission or can
be delivered once the transient potentiation has declined
back to baseline. Two stimulation electrodes were placed
in the lateral amygdala and the subthreshold protocol
was delivered at 30 and 60 min following the washout of
isoprenaline. LTP was induced when the subthreshold
stimulation protocol was delivered 30 min following
isoprenaline washout (128%± 4%, t= 5.3, P= 0.0065,
N= 6, Fig. 6A). However, LTP was not induced when
the subthreshold stimulation protocol was delivered
60 min after isoprenaline washout (98%± 4%, t= 0.49,
P= 0.33, N= 5, Fig. 6A). To determine whether this
sustained potentiation induced by subthreshold
stimulation relied on b1- or b2-ADRs we repeated the
experiments in the presence of metoprolol or ICI 118,551.
LTP was prevented by the b1-ADR antagonist metoprolol
(94 ± 5%, t= 0.72, P= 0.55, N= 4, Fig. 6B) but was
unaﬀected by the b2-ADR antagonist ICI 118,551
(127 ± 4%, t= 8.4, P= 0.001, N= 4, Fig. 6B).
The above results suggest that b1-ADR activation
triggers an intracellular mechanism that lowers the
threshold for LTP and that this intracellular mechanism
outlasts the transient synaptic potentiation. However,
this mechanism itself is transient and was no longer
apparent 60 min after b-ADR activation. This
potentiation was blocked by application of H89,
delivered 30 min prior to the subthreshold protocol (LA–
PRh, 102%± 4%, t= 2.0, P= 0.070, N= 5, Fig. 6B).
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dependent on continued PKA activity triggered by
b1-ADR stimulation.DISCUSSION
Our previous work demonstrated that activity-dependent
LA–PRh LTP was dependent on b-ADRs (Perugini
et al., 2012). In the present study we extend ourinvestigation of plasticity at amygdala–perirhinal and per-
irhinal-perirhinal inputs. We conﬁrm that LTP induced by
HFS at the PRh–PRh input is not dependent on b-ADR
activation by showing that neither b1- nor b2-ADRs antag-
onists prevent LTP. We now demonstrate that LTP
induced by HFS within the LA–PRh is dependent on
b1- but not b2-ADRs. The reason why b1-ADR antagonism
blocked, but b2-ADR antagonism did not block, LTP is not
clear. Both receptor subtypes are thought to couple to the
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1994) and therefore if both receptor subtypes are acti-
vated by endogenous noradrenaline one might expect
both to be involved in LTP. However, the lack of a role
for b2-ADRs might reﬂect a relatively low level of these
receptors in the CNS compared to b1-ADRs (Rainbow
et al., 1984; Tiong and Richardson, 1989).
Previous studies have demonstrated an inﬂuence of
b-ADRs on synaptic plasticity by pairing synaptic
stimulation protocols with application of b-ADR agonists
(Hopkins and Johnston, 1988; Bro¨cher et al., 1992;
Huang and Kandel, 1996; Thomas et al., 1996; Lin
et al., 2003; Choi et al., 2005; Tully et al., 2007). Using
a similar approach of pairing stimulation with b-ADR ago-
nist application produced some completely unexpected
ﬁndings in the current study. Thus, bath application of
10 lM isoprenaline coupled with basal synaptic stimula-
tion resulted in a lasting potentiation at the PRh–PRh
input. This was completely surprising given that b-ADRs
were not necessary for PRh–PRh LTP induced by HFS.
In marked contrast, although b-ADRs were necessary
for LTP induced by HFS at the LA–PRh input there was
only a transient potentiation induced by 10 lM isoprena-
line coupled with basal synaptic stimulation. In previous
work we described that 1 lM isoprenaline had no eﬀect
on baseline transmission (Perugini et al., 2012), indicating
a dose-dependent eﬀect of isoprenaline on the induction
of potentiation at PRh–PRh synapses. Previous studies
using isoprenaline at 1–50 lM in the CA1 region of the
hippocampus and neocortex produced varying results
from ﬁnding isoprenaline either transiently altered base-
line transmission or had no eﬀect (Gelinas and Nguyen,
2005; Seol et al., 2007; Kemp and Manahan-Vaughan,
2008; Salgado et al., 2011).
Importantly these data indicate that although b-ADRs
are not necessary for PRh–PRh LTP induced by HFS
they are present within this pathway and when
appropriately activated (in this case pharmacologically)
can induce a lasting potentiation. b-ADRs couple to
cAMP and PKA signaling and we have previously
shown forskolin application can result in potentiation at
the PRh–PRh input (Perugini et al., 2012). Therefore,
appropriate activation of cAMP and PKA signaling
whether by forskolin or b-ADR activation can contribute
to LTP in the PRh–PRh input.
In contrast to the eﬀect at the PRh–PRh input,
pharmacological activation of b-ADRs by isoprenaline
only produced a transient potentiation at the LA–PRh
input when paired with basal stimulation. However,
stimulation subthreshold for LTP induction coupled with
isoprenaline application did produce LTP at the LA–PRh
input. Together, these results suggest that under
diﬀerent circumstances activation of b-ADRs can result
in LTP at both the LA–PRh and PRh–PRh inputs.
Isoprenaline-induced LTP at both the PRh–PRh and
LA–PRh inputs was prevented by either b1- or b2-ADR
antagonists. This was in contrast to our ﬁnding that LTP
induced by synaptic stimulation alone at the LA–PRh
input is b1-ADR dependent but not b2-ADR dependent.
This therefore suggests that whileb1- or b2-ADRs may
have diﬀerent expression levels (Rainbow et al., 1984;Tiong and Richardson, 1989), they both have the potential
to enhance transmission. Nevertheless the activity-
dependent protocols that induce LTP at the LA–PRh input
in this study only required b1-ADRs.
An alternative explanation for the diﬀerential eﬀects of
isoprenaline on synaptic transmission at the PRh–PRh
input versus the LA–PRh input is that the threshold for
induction of LTP that relies on b-ADR activation is lower
at the PRh–PRh input than at the LA–PRh input. This
could explain why b-ADR activation by isoprenaline in the
PRh–PRh input results in LTP when coupled with basal
stimulation at 0.033 Hz but a short burst of 100-Hz
stimulation is required to be coupled with isoprenaline
stimulation at the LA–PRh input. The diﬀerent stimulation
protocols will most likely produce diﬀerent levels of
NMDA receptor and L-type VGCC activation with lower
levels being required at the PRh–PRh input compared to
the LA–PRh input.
Interestingly, HFS-induced LTP and isoprenaline-
induced potentiation in the PRh–PRh input did not
occlude one another, suggesting that diﬀerent mec-
hanisms may underlie these forms of lasting potentiation.
However, our previous data (Perugini et al., 2012) and
the current data show that similar intracellular mechanisms
most likely operate in both these forms of potentiation.
Thus it is possible that the ﬁnal expression mechanisms
of potentiation are diﬀerent. In contrast, HFS-induced
LTP did occlude isoprenaline plus subthreshold stimula-
tion-induced potentiation (and vice versa) at the LA–PRh
input. This suggests that the intracellular mechanisms
and/or the expression mechanisms of both forms of poten-
tiation at the LA–PRh input are likely to be similar.
Since the isoprenaline-induced potentiation in both the
PRh–PRh and the LAPRh inputs was stimulus-dependent
we hypothesized that- this potentiatio-n may rely on
glutamate release and activation of glutamate receptors.
Induction of synaptic plasticity requiring subthreshold
stimulation and isoprenaline application has also been
reported previously (Kirkwood et al., 1999; Seol et al.,
2007). We found that blockade of NMDARs with L-
689,560 prevented the isoprenaline-induced potentiation.
The reason for the combined role of b-ADRs and
NMDARs in this form of LTP is not clear but enhancement
of neuronal excitability by b-ADR activation (Heginbotham
and Dunwiddie, 1991; Pedarzani and Storm, 1995) could
promote NMDAR activity and thus promote LTP induc-
tion. Alternatively, there is evidence for a functional link
between b-ADRs and NMDARs as part of a larger
AMPAR, AKAP, b-ADR and NMDAR signaling complex
located at the plasma membrane (Colledge et al., 2000;
O’Dell et al., 2010). In addition, a direct interaction
between AMPARs and b-ADRs receptors has been pos-
tulated to result in the phosphorylation of the GluR1
AMPAR subunit and an increase in surface AMPARs
(Joiner et al., 2010) which may underlie either or both
transient potentiation and LTP. Finally, it is possible that
b-ADR activation enhances downstream cascades trig-
gered by NMDAR activation (Seol et al., 2007). In addi-
tion, both transient potentiation at the LA–PRh input and
sustained potentiation at the PRh–PRh input were also
prevented by blockade of voltage-gated calcium channels
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previously linked to L-type calcium channels and the
mechanism involves PKA-mediated phosphorylation of
the L-type calcium channels to increase channel conduc-
tance (Catterall, 2000). This suggests that b-ADRs stimu-
lated PKA, NMDARs and calcium channel activity can all
contribute to both the lasting potentiation at the PRh–PRh
and the transient potentiation at the LA–PRh inputs.
In the ﬁnal part of this study we were able to
demonstrate at the LA–PRh input that stimulation
subthreshold for induction of LTP could induce LTP
when delivered 30 min after washout of isoprenaline, at
a time when there was no transient potentiation. This
result is similar to previous ﬁndings in the visual cortex
(Seol et al., 2007) and hippocampus (Gelinas et al.,
2008) and suggests that isoprenaline application pro-
duces some lasting change in synaptic function (that out-
lasts the transient potentiation) that can enhance synaptic
plasticity. Interestingly this form of LTP was blocked by
b1-ADR antagonism but not b2-ADR antagonism and
therefore parallels HFS-induced LTP at this input. The
exact mechanisms underlying this prolonged excitability
remain unknown. However, in our experiments blocking
PKA activity prevented the induction of this form of LTP.
This agrees with a previous study (Gelinas et al., 2008)
suggesting that the mechanism of enhancement of plas-
ticity within the LA–PRh pathway may rely on constitutive
activity of PKA.
In conclusion, this study increases understanding of
mechanisms of synaptic plasticity within the perirhinal
cortex resulting from intracortical stimulation and also
following activity of the lateral amygdala output to
perirhinal cortex. These mechanisms may be important
for visual recognition memory and for modulation of
such memory by emotional experience.
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